Efficacy of two-time prophylactic intravenous administration of tazobactam/piperacillin for transrectal ultrasound-guided needle biopsy of the prostate

Crawford, 1982, Prevention of urinary tract infection and sepsis following transrectal prostate biopsy, J Urol, 127, 449 Linvert, 2000, Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy, J Urol, 164, 76 Ruebush, 1979, A double-blind study oftrimethoprim-sulfamethoxazole prophylaxis in patients having transrectal needle biopsy of the prostate, J Urol, 122, 492 Shandera, 1998, Variability in patient preparation for prostate biopsy among American urologists, Urology, 52, 644, 10.1016/S0090-4295(98)00313-6 Drusano, 2000, Fluoroquinolone pharmacodynamics: prospective determination of relationships between exposure and outcome, J Chemother, 12, 21, 10.1080/1120009X.2000.11782309 Griffith, 2002, Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk, J Urol, 168, 1021 Shigehara, 2009, Detection of drug-resistant Escherichia coli in patients with complicated cystitis: analysis of risk factors, Int J Urol, 16, 808, 10.1111/j.1442-2042.2009.02360.x Ishikawa, 2011, The nationwide study of bacterial pathogens associated with urinary tract infections conducted by the Japanese Society of Chemotherapy, J Infect Chemother, 17, 126, 10.1007/s10156-010-0174-1 Liss, 2011, Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy, J Urol, 185, 1283 Alex, 2012, Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies. Time to reassessant microbial prophylaxis?, Eur Urol, 62, 453, 10.1016/j.eururo.2012.04.044 Hasegawa, 2002, Fatal septic shock caused by transrectal needle biopsy of the prostate. A case report, Kansenshogaku Zasshi, 76, 893, 10.11150/kansenshogakuzasshi1970.76.893 Borer, 1999, Fatal Clostridium sordellii ischio-rectal abscess with septicaemia complicating ultrasound-guided transrectal prostate biopsy, J Infect, 38, 128 Kobori, 2008, Free-to-total prostate-specific antigen (PSA) ratio contributes to an increased rate of prostate cancer detection in a Japanese population screened using a PSA level of 2.1-10.0 ng/ml as a criterion, Int J Clin Oncol, 13, 229, 10.1007/s10147-007-0742-2 Kapoor, 1998, Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy, Urology, 52, 552, 10.1016/S0090-4295(98)00296-9 Riebergen, 1997, Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program, Urology, 49, 875, 10.1016/S0090-4295(97)00100-3 Djavan, 2001, Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study, J Urol, 166, 856 Wolf, 2008, Best practice policy statement on urologic surgery antimicrobial prophylaxis, J Urol, 179, 1379 Zani, 2011, Antibiotic prophylaxis for transrectal prostate biopsy, Cochrane Database Syst Rev, 5, CD006576 Matsumoto, 2007, Japanese guidelines for prevention of perioperative infections in urological field, Int J Urol, 14, 890, 10.1111/j.1442-2042.2007.01869.x Steensels, 2012, Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy–should we reassess our practices for antibiotic prophylaxis?, Clin Microbiol Infect, 18, 575, 10.1111/j.1469-0691.2011.03638.x Shigehara, 2008, Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis, J Infect Chemother, 14, 40, 10.1007/s10156-007-0570-3 Brewster, 1995, Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective randomized trial of cefuroxime versus piperacillin/tazobactam, Br J Urol, 76, 351, 10.1111/j.1464-410X.1995.tb07713.x Cormio, 2002, Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective study of ciprofloxacin vs piperacillin/tazobactam, BJU Int, 90, 700, 10.1046/j.1464-410X.2002.02991.x Yasuda, 2014, Effectiveness and safety of tazobactam/piperacillin 4.5 g for the prevention of febrile infectious complication after prostate biopsy, J Infect Chemother, 20, 631, 10.1016/j.jiac.2014.06.011 Ambrose, 2003, Pharmacokinetics-pharmacodynamics of cefepime and piperacillin-tazobactam against Escherichia coli and Klebsiella pneumoniae strains producing extended spectrum beta-lactamases: report from the ARREST program, Antimicrob Agents Chemother, 47, 1643, 10.1128/AAC.47.5.1643-1646.2003 Drusano, 1997, Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections, J Chemother, 9, 38 Shiba, 2011, Dosage and administration schedule adjustment of tazobactam/piperacillin based on PK-PD analysis in patients with renal dysfunction, Jpn J Chemother, 59, 359 Panupong, 2009, Reduction in bacteremia rates after rectum sterilization before transrectal, ultrasound-guided prostate biopsy: a randomized controlled trial, J Med Assoc Thai, 92, 1621 Park, 2009, Simple use of the suppository type povidone-iodine can prevent infectious complications in transrectal ultrasound-guided prostate biopsy, Adv Urol, 2009, 750598, 10.1155/2009/750598 Pu, 2014, Reducing the risk of infection for transrectal prostate biopsy with povidone-iodine: a systematic review and meta-analysis, Int Urol Nephrol, 46, 1691, 10.1007/s11255-014-0713-2